Imunon IMNN
NASDAQ IMNN
$1.11 +0.11 (+10.36%)
As of: Oct 21, 2026 · 2:49 PM EDT

Imunon (IMNN) Minority Interest (2011)

Updated

Imunon's Minority Interest came in at $597,744 for Q2 2011.

Analysis

Imunon (IMNN) Minority Interest (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn
10 Imunon 5.86 Mn 5.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 597,744.00
API Access

Imunon Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=IMNN&period=max&api_key=YOUR_API_KEY